Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leiomyosarcoma Uterus × Trabectedin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 19 Ovarian Neoplasms 7 Leiomyosarcoma 5 Liposarcoma 4 Liposarcoma, Myxoid 3 Sarcoma, Ewing 2 Osteosarcoma 2 Solitary Fibrous Tumors 1 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Epithelial Cancer Recurrent 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leiomyosarcoma Uterus 1 Ichthyosis, X-Linked 1 Histiocytoma, Malignant Fibrous 1 Hemangioendothelioma 1 Fanconi Anemia, Complementation Group D1 1 Chondrosarcoma 1 Carcinosarcoma 1 Cancers With DNA Repair-Deficiency 1 Bone Neoplasms 1

Interventions

Trabectedin 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06524583 2025-03-30

L-UteCIN

UNICANCER

Phase 2 Recruiting

Leiomyosarcoma Uterus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡